We have recently cloned and characterized pharmacologically a chicken angiotensin II receptor (cAT). To evaluate its putative role in developmental processes, we investigated its spatio-temporal distribution in the chicken embryo up to E14. The cAT mRNA is expressed in a developmental manner in the mesonephros and allantois, as well as in the heart, branchial arches or limbs. These results, the ®rst to report the embryonic distribution of an angiotensin receptor in a non-mammalian species, show that its expression pattern does not correspond to either one of the two angiotensin receptor types in mammalian species. q
Results and discussion
The role of angiotensin II (AngII) in embryonic development raises a great interest because AngII receptors (AT) are widespread and abundantly expressed in fetal tissues of mammalian species (Shanmugam and Sandberg, 1996) . The precise developmental role of this peptide, mostly known for its effects in adult cardiovascular physiology, remains, to date, largely unknown. Whereas, in mammals, two molecularly distinct types of AngII receptors (AT1 and AT2) have been identi®ed (Murphy et al., 1991; Kambayashi et al., 1993; Mukoyama et al., 1993) , there is a single type cloned so far in avians (Murphy et al., 1993; Kempf et al., 1996) . The avian receptor shares approximately 75% identity with AT1, but cannot be classi®ed as a type 1 or 2 receptor on a pharmacological basis (Murphy et al., 1993; Kempf et al., 1996) , or on its pattern of distribution in adults (Kempf et al., 1996) . Since the AT1 and AT2 embryonic tissue distribution in mammals is well established for both types (Grady et al., 1991; Shanmugam et al., 1994; Shanmugam et al., 1995) , we thought the expression pattern of the cAT in the chicken embryo may give some new insights about its classi®cation and putative functions.
During embryonic development, the cAT mRNA revealed by in situ hybridization is most abundant in the developing kidney and the allantois (Fig. 1) , compared to the rest of the embryo (Fig. 2) . No hybridization signal was observed with the sense probe (insert in Fig. 1A) .
The earliest hybridization signal is located in the nephrogenous mesenchyme around HH15, all along the nephric duct of the mesonephros (arrowheads in Fig. 1A,B) . The distribution of the cAT mRNA positive cells reproduces the migration pathway of the mesenchymal cells which participate in the glomerular differentiation: ®rst, the positive cells surround the epithelial structures (Fig. 1B) , then some invaginate into the cleft of the S-shape bodies ( Fig.  1C ) and ®nally settle within the glomerular tuft ( Fig. 1D,E ). Once within, the glomerular positive cells maintain cAT expression until mesonephros degenerates (Fig. 1E) . Later, cAT becomes distributed in metanephros (not shown) and adrenal gland (Fig. 1F ,G) as in the adult (Kempf et al., 1996) . These data suggest that cAT may play a role in nephrogenesis, as previously shown for AngII receptors in rodents and amphibians (Tufro-McReddie et al., 1995; Oliverio et al., 1998; Pope et al., 1998) and very recently in men (Nishimura et al., 1999) . In the incipient allantois and throughout its formation, cAT is expressed early and at very high levels (Fig. 1H,I ), but exclusively in the mesenchymal layer and not in the endodermal layer (Fig. 1J) .
Within the developing heart, from E4, cAT expression is con®ned to the cardiomyocytes of the ventricular trabeculae ( Fig. 2A) . Simultaneously, cAT appears in the distal ectomesenchyme of the branchial arches, but is not observed in the ectoderm, the endoderm or the core mesoderm (Fig. 2B) . A hybridization signal also appears in the dermatome along the vertebral axis at site and time of dermatome-dermis (epithelio-mesenchymal) conversion (Fig. 2C) , and remains detectable from this stage onward in derived dermal structures (not shown). The cAT transcript is also present in the mesenchymal tissues of the respiratory and gastrointestinal tracts where it displays a very characteristic spatio-temporal pattern of expression (asterisk in Figs. 1A and 2D,E) . We observe at various sites throughout the whole embryo a transient expression of the cAT mRNA in mesenchymal cell condensations around cartilages (Fig. 2F,G) . Finally, two strictly de®ned sites of expression are localized in the wall of the diencephalon (Fig. 2H ) and in the laryngotracheal groove epithelium (Fig. 2I) .
In conclusion, this ®rst report of the embryonic expression pattern of an AngII receptor in a non-mammalian species shows that the chicken AngII receptor is expressed in many different mesenchymal tissues. Interestingly, this tissue speci®city is rather a characteristic of the mammalian AT2 receptor, although the chicken AT receptor is molecularly closer to the mammalian AT1 than AT2 receptor type. This discrepancy makes of the cAT an atypical receptor that cannot be readily assimilated to either one of the two AngII receptor types. In line with previous pharmacological and functional studies (Murphy et al., 1993; Nishimura et al., 1994; Kocsis et al., 1995; Kempf et al., 1996) , our results reinforce evidence for another AngII receptor in the avian class. Cloning of this putative receptor will clarify the role of AngII in chick development.
Materials and methods
Antisense and sense RNA probes were obtained from the chicken AngII receptor cDNA, cloned in pcRII, by in vitro transcription using T7 and SP6 RNA polymerases after linearization with HindIII and XhoI, respectively (Kempf et al., 1996) . The in situ experiments were performed on embryos ®xed in 4% PFA and paraf®n embedded as previously described in detail (Sibony et al., 1995) .
